Group 1 - The company plans to repurchase shares through centralized bidding, with a repurchase amount between 20 million and 45 million yuan, and a maximum repurchase price of 45.75 yuan per share [1] - The current stock price is 27.45 yuan, reflecting a cumulative increase of 46.06% this year, and the proposed maximum repurchase price is 66.67% higher than the current price [1] - This is the second share repurchase announcement this year, with the first one on September 13, 2025, involving a repurchase amount between 30 million and 55 million yuan at a maximum price of 40.69 yuan per share [1] Group 2 - As of October 31, the company has 12,600 shareholders, an increase of 0.54% from the previous period, with an average of 15,813 circulating shares per shareholder, a decrease of 0.54% [2] - For the period from January to September 2025, the company achieved operating revenue of 435 million yuan, a year-on-year increase of 16.03%, while the net profit attributable to the parent company was -13.83 million yuan, a year-on-year decrease of 193.67% [2] - The company has cumulatively distributed 116 million yuan in dividends since its A-share listing, with 79.23 million yuan distributed over the past three years [3]

Group 1 - Company announced a share repurchase plan with a total funding of no less than RMB 20 million and no more than RMB 45 million, with a maximum repurchase price of RMB 45.75 per share [1] - The repurchased shares will be used for employee stock ownership plans or equity incentives [1] - The repurchase period will last up to 12 months from the board's approval date [1] Group 2 - As of the report, the company's market capitalization is RMB 5.5 billion [2] - The company's revenue composition for 2024 shows that inorganic non-metal functional powder materials account for 99.64%, while other businesses account for 0.36% [1]

证券代码：688733 证券简称：壹石通 公告编号：2025-060 安徽壹石通材料科技股份有限公司 关于 2025 年第二次以集中竞价交易方式回购公司股份 方案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 回购股份金额：不低于人民币 2,000 万元（含），不超过人民币 4,500 万元 （含）。 ● 回购股份资金来源：自有资金或自筹资金（含股票回购专项贷款资金等）。 ● 回购股份用途：本次回购的股份将在未来适宜时机用于员工持股计划或股 权激励，并在公司披露股份回购实施结果暨股份变动公告日之后的三年内予以转 让；若公司本次回购的股份未能在上述三年内转让完毕，公司将依法履行减少注 册资本的程序，未转让股份将予以注销。如国家对相关政策作出调整，则本回购 方案按调整后的政策实行。 ● 回购股份价格：本次回购股份的价格不超过人民币 45.75 元/股（含），不高 于公司董事会通过回购股份决议前 30 个交易日公司股票交易均价的 150%。 ● 回购股份方式：集中竞价交易方式。 ● 回购股份期限：自公 ...

壹石通(688733.SH)发布公告，公司拟斥2000万元至4500万元回购股份，回购股份的价格不超过45.75元/ 股，回购的股份将在未来适宜时机用于员工持股计划或股权激励。 ...

智通财经APP讯，壹石通(688733.SH)发布公告，公司拟斥2000万元至4500万元回购股份，回购股份的 价格不超过45.75元/股，回购的股份将在未来适宜时机用于员工持股计划或股权激励。 ...

本次回购股份的价格不超过人民币45.75元/股（含），不高于公司董事会通过回购股份决议前30个交易 日公司股票交易均价的150%。 本次回购的股份将在未来适宜时机用于员工持股计划或股权激励，并在公司披露股份回购实施结果暨股 份变动公告日之后的三年内予以转让；若公司本次回购的股份未能在上述三年内转让完毕，公司将依法 履行减少注册资本的程序，未转让股份将予以注销。如国家对相关政策作出调整，则本回购方案按调整 后的政策实行。 格隆汇11月25日丨壹石通(688733.SH)公布,公司拟不低于人民币2000万元（含），不超过人民币4500万 元通过集中竞价交易方式回购公司已发行的人民币普通股（A 股）股票。 ...

二、董事会会议审议情况 全体董事对本次会议议案进行了审议，以记名投票表决方式，通过如下决 议： （一）审议通过《关于2025年第二次以集中竞价交易方式回购公司股份方 案的议案》 证券代码：688733 证券简称：壹石通 公告编号：2025-059 安徽壹石通材料科技股份有限公司 第四届董事会第十五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 安徽壹石通材料科技股份有限公司（以下简称"公司"）第四届董事会第 十五次会议于2025年11月24日在公司董事会会议室以现场结合线上方式召开， 会议通知于2025年11月21日以书面方式发出。本次会议由董事长蒋学鑫先生提 议召开并主持，会议应出席董事9名，实际出席董事9名。本次会议的召集、召 开和表决程序符合《公司法》等法律法规、规范性文件和《公司章程》的有关 规定。 表决结果：9票同意，0票反对，0票弃权；表决通过。 本议案无需提交公司股东会审议。 特此公告。 安徽壹石通材料科技股份有限公司 董事会 2025年11月26日 公司本次使用自有或 ...

Group 1 - Huafeng Co., Ltd. announced a stock suspension due to a potential change in control after signing a share transfer intention agreement [1] - Keshida plans to reduce its shareholding by up to 424,000 shares, representing 0.07% of its total share capital [1] - Jinqilin intends to distribute a cash dividend of 0.10 yuan per share, totaling 19.61 million yuan [1] Group 2 - Rejingshi Biotech has repurchased 904,100 shares, accounting for 0.98% of its total share capital, with a total expenditure of 150 million yuan [2] - Yishitong has repurchased 1,236,500 shares, representing 0.619% of its total share capital, with a total expenditure of approximately 33.49 million yuan [2] Group 3 - Hanjia Design announced the release of a detention on its subsidiary's chairman, allowing him to resume duties [4] - Qingmu Technology plans to acquire 65.83% of Vitalis Pharma AS for 300 million Norwegian Krone (approximately 212 million yuan) [4] - Anda Intelligent's shareholder plans to reduce its stake by up to 2.74% [4] Group 4 - Wansheng Intelligent is a candidate for a project with a pre-bid amount of approximately 42.99 million yuan, representing 4.56% of its audited revenue for 2024 [4] - Yipin Hong received a drug registration certificate for a medication used to treat Alzheimer's symptoms [4] Group 5 - *ST Sansheng received a total of 254 million yuan from restructuring investors [4] - Haichuang Pharmaceutical received approval for clinical trials of HP518 tablets for advanced prostate cancer treatment [4] Group 6 - Ningbo Huaxiang's subsidiary plans to invest 5 million yuan in a venture capital fund focusing on intelligent industries [4] - Petty Co. plans to repurchase shares worth 50 to 70 million yuan [4] Group 7 - Tongji Technology's subsidiary won a construction project with a bid price of 866 million yuan [4] - Prolo Pharmaceutical received a drug registration certificate for a generic drug [4] Group 8 - Jingyan Technology plans to use up to 1.6 billion yuan of idle funds for financial management [4] - Furan De received government subsidies totaling 34.65 million yuan [4] Group 9 - David Medical's subsidiary's medical device registration has been accepted [4] - Jusaylong plans to increase its subsidiary's capital by 170 million yuan through debt-to-equity conversion [4] Group 10 - Heng Rui Pharmaceutical's application for a drug license has been accepted by the National Medical Products Administration [4] - Lege Co. plans to increase its stake in the company by 40 to 80 million yuan [4] Group 11 - New Beiyang's subsidiary won a project with the Bank of Communications [4] - Jiangxi Changyun plans to publicly transfer land use rights and buildings with a starting price of 7.79 million yuan [4] Group 12 - Shenqi Pharmaceutical's subsidiary has paid approximately 16.67 million yuan in tax and penalties [4] - Panjiang Co. plans to invest 1.334 billion yuan in a power plant project [4] Group 13 - Fashilong's vice president resigned for personal reasons [4] - Chunxue Food received government subsidies of 3.79 million yuan [4] Group 14 - China Galaxy completed the repayment of a short-term financing bond totaling 3.025 billion yuan [4] - Jiuzhou Pharmaceutical received approval for a chemical raw material drug [4] Group 15 - Longqi Technology's subsidiary plans to invest 30 million yuan in a venture capital fund [4]

Core Viewpoint - The company is making steady progress on its solid oxide fuel cell (SOFC) project, with the first 8kW SOFC system installed and currently undergoing system debugging and optimization. The first demonstration project is expected to gradually commence operations in the first quarter of 2026 [1] Group 1 - The solid oxide fuel cell (SOC) project is advancing according to the established plan [1] - The first 8kW SOFC system has been successfully installed [1] - System debugging and optimization are currently in progress [1] Group 2 - The first SOFC demonstration project is anticipated to begin operations in the first quarter of 2026 [1]

Group 1 - The article highlights the advancements in new materials, particularly in the field of glass, showcasing various innovative products such as ultra-thin flexible glass and high-performance hollow glass microspheres [1] - The establishment of a national key laboratory for advanced glass materials aims to focus on critical technologies in ultra-thin electronic glass and new energy glass, with over a hundred technical bottlenecks successfully overcome [1] - The new materials industry in Bengbu, Anhui, has seen significant growth, with 411 companies and an industry scale exceeding 66 billion yuan, forming a collaborative industrial system featuring silicon-based and bio-based new materials [1] Group 2 - Anhui Fengyuan Group is dedicated to the research and development of bio-based new materials, successfully creating a complete industrial chain from upstream lactic acid bacteria preparation to downstream polylactic acid products [3] - The company emphasizes the integration of artificial intelligence and bio-manufacturing to drive a comprehensive green transformation in the economy and society [3] - Anhui Yishitong Material Technology Co., Ltd. has become a national manufacturing "single champion" in the lithium battery safety materials sector, holding nearly 50% of the global market share with its independently developed new materials [3][4] Group 3 - The Anhui North Microelectronics Research Institute has developed a brain-machine interface health cap, showcasing the application of AI and new materials in innovative technologies [6] - The company is focused on overcoming technical bottlenecks in non-invasive gel electrodes and brain signal acquisition chips, promoting the application of brain-machine interface products in various fields [6] - The fifth International New Materials Industry Conference held in Bengbu attracted global participants, aiming to outline a new development blueprint for the new materials industry [6]